Névrite optique rétrobulbaire au cours d’un traitement par infliximab pour une rectocolite hémorragique
Tóm tắt
Từ khóa
Tài liệu tham khảo
European Medicines Agency (EMEA). European Public Assessment Report. Procedural steps taken and scientific information after authorisation).Annexe I. Résumé des caractéristiques du produit Rémicade® : www.emea.europa.eu/.
Strong, 2004, Retrobulbar optic neuritis associated with infliximab in a patient with Crohn disease, Ann Intern Med, 140, W34, 10.7326/0003-4819-140-8-200404200-00037-w4
Tran, 2005, Optic neuritis associated with infliximab, J Fr Ophtalmol, 28, 201, 10.1016/S0181-5512(05)81044-7
Ten Tusscher, 2003, Bilateral anterior toxic optic neuropathy and the use of infliximab, BMJ, 326, 579, 10.1136/bmj.326.7389.579
Rutgeerts, 2005, Infliximab for induction and maintenance therapy for ulcerative colitis, N Engl J Med, 353, 2462, 10.1056/NEJMoa050516
Gupta, 2005, Increased risk for demyelinating diseases in patients with inflammatory bowel disease, Gastroenterology, 129, 819, 10.1053/j.gastro.2005.06.022
Magnano, 2004, Demyelination and inhibition of tumor necrosis factor (TNF), Clin Exp Rheumatol, 22, S134